Soliris (eculizumab) is a brand-name drug prescribed for certain autoimmune conditions in adults and some children. A healthcare professional administers Soliris as an IV infusion. The dosage can ...

Soliris has a US price of $536,629 (according to analysts EP Vantage) per patient per year, making it the most expensive prescription drug on the US market, well known as being the highest cost ...

Investors are anticipating good news from a potential rival to Alexion’s rare disease blockbuster Soliris, with shares in the company behind it soaring. Shares in Akari Therapeutics have tripled ...